Belgian pharmaceutical CDMO, Ardena, has acquired Idifarma, the Spanish contract manufacturer of niche and highly potent generic and innovative drugs, from Suanfarma and Sodena. The acquisition expands Ardena's presence across Southern Europe and supports its strategy of becoming a leading global CDMO, offering integrated solutions across the full pharma development lifecycle. The acquisition brings the [...]
Idifarma is a Spain-based CDMO that provides services including GMP manufacturing, quality control, formulation and analytical development for the pharmaceutical sector.